Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 18, 2010
Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats
Letícia Cruz, Evelise Assumpção, Sérgio F Andrade, et al.
The Journal of Pharmacy and Pharmacology
|
May 24, 2008
Pharmacokinetic evaluation of LASSBio-579: an N-phenylpiperazine antipsychotic prototype
Daniela J Conrado, Hugo Verli, Gilda Neves, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 8, 2021
Development of a model-based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy
Karthik Lingineni, Varun Aggarwal, Juan Francisco Morales, et al.
Pharmacology, Biochemistry, and Behavior
|
December 18, 2007
Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581
Gilda Neves, Michele Kliemann, Andresa H Betti, et al.
Critical Care Medicine
|
January 24, 2019
Midazolam Dose Optimization in Critically Ill Pediatric Patients With Acute Respiratory Failure: A Population Pharmacokinetic-Pharmacogenomic Study
Athena F Zuppa, Daniela J Conrado, Nicole R Zane, et al.
Clinical Pharmacology and Therapeutics
|
January 4, 2020
Hippocampal Neuroimaging-Informed Clinical Trial Enrichment Tool for Amnestic Mild Cognitive Impairment Using Open Data
Daniela J Conrado, Jackson Burton, Derek Hill, et al.
Clinical Pharmacology and Therapeutics
|
January 20, 2020
Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data
Daniela J Conrado, Sridhar Duvvuri, Hugo Geerts, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 7, 2020
Machine Learning in Drug Discovery and Development Part 1: A Primer
Alan Talevi, Juan Francisco Morales, Gregory Hather, et al.
Journal of the American Heart Association
|
February 26, 2018
Genome-Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β-Blockers
Mohamed H Shahin, Daniela J Conrado, Daniel Gonzalez, et al.
Clinical and Translational Science
|
July 28, 2017
Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis
Daniela J Conrado, Timothy Nicholas, Kuenhi Tsai, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 18, 2010
Gastroresistant microparticles containing sodium alendronate prevent the bone loss in ovariectomized rats
Letícia Cruz, Evelise Assumpção, Sérgio F Andrade, et al.
The Journal of Pharmacy and Pharmacology
|
May 24, 2008
Pharmacokinetic evaluation of LASSBio-579: an N-phenylpiperazine antipsychotic prototype
Daniela J Conrado, Hugo Verli, Gilda Neves, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 8, 2021
Development of a model-based clinical trial simulation platform to optimize the design of clinical trials for Duchenne muscular dystrophy
Karthik Lingineni, Varun Aggarwal, Juan Francisco Morales, et al.
Pharmacology, Biochemistry, and Behavior
|
December 18, 2007
Serotonergic neurotransmission mediates hypothermia induced by the N-phenylpiperazine antipsychotic prototypes LASSBio-579 and LASSBio-581
Gilda Neves, Michele Kliemann, Andresa H Betti, et al.
Critical Care Medicine
|
January 24, 2019
Midazolam Dose Optimization in Critically Ill Pediatric Patients With Acute Respiratory Failure: A Population Pharmacokinetic-Pharmacogenomic Study
Athena F Zuppa, Daniela J Conrado, Nicole R Zane, et al.
Clinical Pharmacology and Therapeutics
|
January 4, 2020
Hippocampal Neuroimaging-Informed Clinical Trial Enrichment Tool for Amnestic Mild Cognitive Impairment Using Open Data
Daniela J Conrado, Jackson Burton, Derek Hill, et al.
Clinical Pharmacology and Therapeutics
|
January 20, 2020
Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data
Daniela J Conrado, Sridhar Duvvuri, Hugo Geerts, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 7, 2020
Machine Learning in Drug Discovery and Development Part 1: A Primer
Alan Talevi, Juan Francisco Morales, Gregory Hather, et al.
Journal of the American Heart Association
|
February 26, 2018
Genome-Wide Association Approach Identified Novel Genetic Predictors of Heart Rate Response to β-Blockers
Mohamed H Shahin, Daniela J Conrado, Daniel Gonzalez, et al.
Clinical and Translational Science
|
July 28, 2017
Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis
Daniela J Conrado, Timothy Nicholas, Kuenhi Tsai, et al.
Page
of 3